An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine.

ABSTRACT:

Background

New vaccine technologies may improve the acceptability, delivery (potentially enabling self-administration), and product efficacy of influenza vaccines. One such technology is the microneedle patch (MNP), a skin delivery technology currently in development. Although MNPs hold promise in preclinical studies, their potential economic and epidemiologic impacts have not yet been evaluated.

Methods

We utilized a susceptible-exposed-infectious-recovered (SEIR) transmission model linked to an economic influenza outcomes model to assess the economic value of introducing the MNP into the current influenza vaccine market in the United States from the third-party payer and societal perspectives. We also explored the impact of different vaccination settings, self-administrati

SUBMITTER: Lee BY 

PROVIDER: S-EPMC4623320 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature